for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Mediclinic International PLC

MDCM.L

Latest Trade

291.80GBp

Change

-2.20(-0.75%)

Volume

442,301

Today's Range

286.80

 - 

299.80

52 Week Range

232.40

 - 

386.90

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
294.00
Open
299.80
Volume
442,301
3M AVG Volume
12.01
Today's High
299.80
Today's Low
286.80
52 Week High
386.90
52 Week Low
232.40
Shares Out (MIL)
737.24
Market Cap (MIL)
2,146.85
Forward P/E
24.39
Dividend (Yield %)
--

Next Event

Q4 2021 Mediclinic International PLC Trading Statement Release

Latest Developments

More

Mediclinic Says Hirslanden Has Completed Placement Of A Chf145m Fixed-Rate Bond At Coupon Of 1.25%

Mediclinic International Sees Pressures, Uncertainties To Persist During Q4

Mediclinic To Suspend Final Decision On Pay-Outs Earned By Exec Directors

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Mediclinic International PLC

Mediclinic International plc (Mediclinic) is an international private healthcare services provider. Mediclinic is focused on providing acute-care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic’s operational divisions includes Hirslanden Switzerland, Mediclinic Southern Africa and Mediclinic Middle East. Mediclinic comprises of 77 hospitals, five sub-acute hospitals, 14 day case clinics and 22 outpatient clinics. Hirslanden Switzerland operates 17 hospitals, two day case clinics and three outpatient clinics in Switzerland with over 1900 inpatient beds. Mediclinic Southern Africa operates 53 hospitals, five sub-acute hospitals and 10 day case clinics across South Africa and three hospitals in Namibia with over 8500 inpatient beds. Mediclinic Middle East operates seven hospitals, two day case clinics and 19 outpatient clinics with over 900 inpatient beds in the United Arab Emirates.

Industry

Healthcare Facilities

Contact Info

6th Fl, 65 Gresham Street

EC2V 7NQ

United Kingdom

+44.20.79549600

https://www.mediclinic.com/

Executive Leadership

Dame Inga Beale

Chairman of the Board

Ronnie van der Merwe

Group Chief Executive Officer, Executive Director

Jurgens Myburgh

Group Chief Financial Officer, Executive Director

David Hadley

Chief Executive Officer - Mediclinic Middle East

Daniel Liedtke

Chief Executive Officer - Hirslanden

Key Stats

2.36 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

2.9K

2019

2.9K

2020

3.1K

2021(E)

2.9K
EPS (GBp)

2018

30.000

2019

26.900

2020

24.000

2021(E)

11.938
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.72
Price To Book (MRQ)
0.74
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
91.18
LT Debt To Equity (MRQ)
81.98
Return on Investment (TTM)
-6.37
Return on Equity (TTM)
-5.66

Latest News

Latest News

Hospital operator Mediclinic's half year profit drops 86%

Hospital chain operator Mediclinic International Plc reported an 86% drop in profits for the half year ended Sept. 30, the company said on Thursday.

UPDATE 1-Hospital operator Mediclinic sees full-year loss widen

Mediclinic International Plc, owner of a chain of private hospitals in southern Africa, the Middle East and Switzerland, reported a net loss for the full year that ended on March 31, the company said on Tuesday.

CORRECTED-Hospital operator Mediclinic posts annual loss of 315 mln stg

Mediclinic International Plc, owner of a chain of private hospitals in southern Africa, the Middle East and Switzerland, reported a net loss for the full year that ended on March 31, the company said on Tuesday.

BRIEF-Mediclinic International FY Adjusted Operating Profit Down 5%

* MEDICLINIC INTERNATIONAL PLC - GROUP ADJUSTED RESULTS BROADLY IN LINE WITH EXPECTATIONS DESPITE IMPACT OF COVID-19

BRIEF-Mediclinic Says Covenant Test Waivers Agreed, Suspends Dividend

* COVENANT TEST WAIVERS AGREED IN RESPECT OF MATERIAL BORROWINGS ACROSS ALL THREE DIVISIONS UP TO AND INCLUDING MARCH 2021

BRIEF-Mediclinic International Appoints Dame Inga Beale As Independent Non-Executive Director, Chair Designate

* MEDICLINIC INTERNATIONAL - APPOINTMENT OF DAME INGA BEALE AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHAIR DESIGNATE WITH EFFECT FROM 26 MARCH 2020

South Africa's Mediclinic names former Lloyd's of London CEO as next chair

Mediclinic International Plc has appointed former chief executive of Lloyd's of London, Inga Beale, as an independent non-executive director and its next chairwoman, the company said on Friday.

BRIEF-Mediclinic appoints former Lloyd's of London CEO Beale as chair designate

* SAYS APPOINTS DAME INGA BEALE AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHAIR DESIGNATE WITH EFFECT FROM 26 MARCH 2020.

BRIEF-Mediclinic S. Africa Approves Acquisition Of Matlosana Hospitals

* JSE: MEI - MEDICLINIC SOUTHERN AFRICA ANNOUNCES APPROVAL FOR THE ACQUISITION OF MATLOSANA HOSPITALS

BRIEF-Mediclinic International Announces Acquisition Of Matlosana Hospitals In South Africa

* MEDICLINIC INTNL PLC - ACQUISITION OF MATLOSANA HOSPITALS IN SOUTH AFRICA

Mediclinic International reports 4% rise in H1 profit

Mediclinic International Plc <MEIJ.J> <MDCM.L> reported a 4% rise in half-year core earnings on Thursday as the company's Swiss business adjusted to regulatory changes and its South African and Middle Eastern operations performed well.

CORRECTED-Mediclinic first-half core earnings up 4%

Mediclinic International Plc reported a 4% rise in half-year core earnings on Thursday as the healthcare company's Swiss business adjusted to regulatory changes and its South African and Middle Eastern operations performed well.

UPDATE 1-Mediclinic International sees higher first-half core profit

Mediclinic International Plc said on Wednesday it expects higher first-half core earnings, as the healthcare company's Swiss business adjusted to regulatory changes and its Southern Africa and Middle East operations performed well.

Mediclinic International sees higher first-half core profit

Mediclinic International Plc <MDCM.L> <MEIJ.J> said on Wednesday it expects an increase in first-half core earnings, as the healthcare company's Swiss business adjusted to regulatory changes and its South Africa and Middle East operations performed well.

UPDATE 1-Mediclinic core profit falls on Swiss regulatory changes

Mediclinic International Plc, reported a 4% fall in full-year core profit on Thursday, in line with market expectations, hit by regulatory changes for its Swiss business.

BRIEF-Mediclinic's Swiss Hospital Operators Have Been Affected By Outpatient Tariff Reductions

* MEDICLINIC INTERNATIONAL PLC - GROUP ADJUSTED FULL-YEAR FINANCIAL RESULTS IN LINE WITH MARKET EXPECTATIONS

Mediclinic FY core profit falls on Swiss regulatory changes

Mediclinic International Plc, reported a 4% fall in full-year core profit on Thursday, in line with market expectations, reflecting the impact of regulatory changes on its Swiss business.

Mediclinic expects core profit to drop 3.5 pct for full year

Mediclinic International Plc said it expects full-year group core profit to fall by 3.5 percent, in line with market expectations in a challenging healthcare environment.

BRIEF-Mediclinic International Says 2019 Results Were In Line With Market Expectations

* GROUP RESULTS FOR 2019 FINANCIAL YEAR WERE IN LINE WITH MARKET EXPECTATIONS

UPDATE 2-Mediclinic to cuts Swiss capex, open more outpatient surgery units

Mediclinic International Plc plans to reduce capex for its Swiss business, open more outpatient surgery units and medical centres in order to mitigate regulatory challenges in Switzerland's healthcare market.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up